FindTrial
Sign In

Effect of dexmedetomidine on prevention of postoperative nausea and vomiting in pediatric strabismus surgery

Effect of dexmedetomidine on prevention of postoperative nausea and vomiting in pediatric strabismus surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800020176
Enrollment
Unknown
Registered
2018-12-19
Start date
2018-12-20
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative nausea and vomiting in pediatric strabismus surgery

Interventions

Group DEX1:dexmedetomidine 0.3 ug/kg
Group DEX2:dexmedetomidine 0.5 ug/kg
Group Placebo:normal saline

Sponsors

Eye & ENT Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 10 Years

Inclusion criteria

Inclusion criteria: Under general anesthesia for strabismus surgeries, 6 to 10 years old, American Society of Anesthesiologists (ASA) physical status I to II

Exclusion criteria

Exclusion criteria: Primary exclusion criteria included children with known gastroesophageal reflux, intake of antiemetic or psychoactive medication within 24 hours, developmental delays and allergy to the study medications.

Design outcomes

Primary

MeasureTime frame
postoperative nausea and vomiting;—

Secondary

MeasureTime frame
postoperative emergence agitation;Oculocardiac reflex;postoperative pain;—

Countries

China

Contacts

Public ContactJie Jia

Eye & ENT Hospital, Fudan University

jiajie@eentanesthesia.com+86 13641839213

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 18, 2026